SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 172 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $9,795,000 | +1.7% | 653,000 | -40.3% | 0.44% | -14.2% |
| Q2 2017 | $9,630,000 | +121.0% | 1,094,305 | +30.6% | 0.51% | +206.0% |
| Q1 2017 | $4,357,000 | +70.5% | 837,963 | 0.0% | 0.17% | +60.0% |
| Q4 2016 | $2,556,000 | +374.2% | 837,963 | +1575.9% | 0.10% | +425.0% |
| Q3 2014 | $539,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |